Summary

Rapid Tests Market Summary

The global rapid tests market size was estimated at USD 12.76 billion in 2025 and is projected to reach USD 19.30 billion by 2033, growing at a CAGR of 5.31% from 2026 to 2033. The growth can be attributed to the growing geriatric population, rising target disease burden, and increasing adoption of self-testing & point-of-care products.

Respiratory tract infections (URIs) remain extremely common worldwide, with incidence rates exceeding 162,000 per 100,000 people in recent global estimates, underscoring the need for rapid differentiation of viral versus bacterial causes in clinical practice. Respiratory tract infections (URTIs) remain a major global health concern in 2025, with high incidence rates particularly in children under 5 and adults with underlying conditions. Children under 5 are the most affected group for URTIs, while 97% of pediatric RSV deaths occur in low- and middle-income countries.

Furthermore, Respiratory syncytial virus (RSV) is a highly prevalent viral infection, particularly impacting infants, young children, and older adults. Globally, RSV is estimated to cause approximately 33 million acute lower respiratory tract infections annually in children under five years, with over 3 million cases requiring hospitalization. In the U.S., RSV leads to 58,000-80,000 hospitalizations and 100-300 deaths among children under five each year, as well as 60,000-160,000 hospitalizations and 6,000-10,000 deaths among adults aged 65 and older. Seasonal outbreaks typically occur during fall and winter, significantly impacting healthcare systems and highlighting the critical need for effective diagnostic and preventive measures.

Global Rapid Tests Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global rapid tests market based on product, technology, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Instruments
• Consumables
• Others
• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Immunoassay
• Molecular Diagnostics
• Other technologies
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Respiratory tract infections
o Influenza and Parainfluenza Virus
o Respiratory Syncytial Virus
o Streptococcus
o Other
• Sexually Transmitted Infections (STIs)
• Antibiotic-Resistant Infections (MRSA, Streptococcus Pneumonia, And Others)
• Gastrointestinal Infections
• Sepsis
o Bacterial Sepsis
o Fungal Sepsis and Others
• Tropical & Vector-borne Diseases
• Other
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals & Clinics
• Laboratories
• At-home testing and Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o Japan
o China
o India
o Australia
o South Korea
o Thailand
• Latin America
o Brazil
o Argentina
• Middle East and Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwait

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Market Definitions
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Type and Product Snapshot
2.3. Application and End Use Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Increasing adoption of self-testing & point-of-care products, and introduction of CLIA waived tests
3.3.1.2. Growing geriatric population base
3.3.1.3. Introduction of advance technology enabled products
3.3.1.4. Growing prevalence of target diseases
3.3.2. Market Restraint Analysis
3.3.2.1. Presence of ambiguous regulatory and reimbursement framework for primary care setting
3.3.2.2. Rapid testing sensitivity and accuracy
3.4. Business Environment Analysis
3.4.1. PESTLE Analysis
3.4.2. Porter’s Five Forces Analysis
3.5. COVID-19 Impact Analysis
Chapter 4. Technology Business Analysis
4.1. Rapid Tests Market: Technology Movement Analysis, 2025 & 2033
4.2. Molecular Diagnostics
4.2.1. Molecular Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3. Immunoassay
4.3.1. Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4. Others
4.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Product Business Analysis
5.1. Rapid Tests Market: Product Movement Analysis, 2025 & 2033
5.2. Instruments
5.2.1. Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3. Consumables
5.3.1. Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4. Others
5.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Application Business Analysis
6.1. Rapid Tests Market: Application Movement Analysis, 2025 & 2033
6.2. Respiratory tract infections
6.2.1. Respiratory Tract Infections Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.2.2. Influenza and Parainfluenza Virus
6.2.2.1. Influenza and Parainfluenza Virus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.2.3. Respiratory Syncytial Virus
6.2.3.1. Respiratory Syncytial Virus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.2.4. Streptococcus
6.2.4.1. Streptococcus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.2.5. Other
6.2.5.1. Other Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3. Sexually Transmitted Infections (STIs)
6.3.1. Sexually Transmitted Infections (STIs)Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Antibiotic-Resistant Infections (MRSA, Streptococcus Pneumonia, And Others)
6.4.1. Antibiotic-Resistant Infections (MRSA, Streptococcus Pneumonia, And Others) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Gastrointestinal Infections
6.5.1. Gastrointestinal Infections Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Sepsis
6.6.1. Sepsis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.2. Bacterial Sepsis
6.6.2.1. Bacterial Sepsis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.3. Fungal Sepsis and Others
6.6.3.1. Fungal Sepsis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Tropical & Vector-borne Diseases
6.7.1. Tropical & Vector-borne Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Other
6.8.1. Other Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. End Use Business Analysis
7.1. Rapid Tests Market: End Use Movement Analysis, 2025 & 2033
7.2. Hospitals & Clinics
7.2.1. Hospitals & Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3. Laboratories
7.3.1. Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4. At-home testing and Others
7.4.1. At-home testing and Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Regional Market Snapshot
8.2. North America
8.2.1. North America Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.2.2.2. Key Country Dynamics
8.2.2.3. Regulatory Framework
8.2.2.4. Competitive Scenario
8.2.3. Canada
8.2.3.1. Canada Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.2.3.2. Key Country Dynamics
8.2.3.3. Regulatory Framework
8.2.3.4. Competitive Scenario
8.2.4. Mexico
8.2.4.1. Mexico Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.2.4.2. Key Country Dynamics
8.2.4.3. Regulatory Framework
8.2.4.4. Competitive Scenario
8.3. Europe
8.3.1. Europe Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.2. Germany
8.3.2.1. Germany Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.2.2. Key Country Dynamics
8.3.2.3. Regulatory Framework
8.3.2.4. Competitive Scenario
8.3.3. UK
8.3.3.1. UK Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.3.2. Key Country Dynamics
8.3.3.3. Regulatory Framework
8.3.3.4. Competitive Scenario
8.3.4. France
8.3.4.1. France Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.4.2. Key Country Dynamics
8.3.4.3. Regulatory Framework
8.3.4.4. Competitive Scenario
8.3.5. Italy
8.3.5.1. Italy Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.5.2. Key Country Dynamics
8.3.5.3. Regulatory Framework
8.3.5.4. Competitive Scenario
8.3.6. Spain
8.3.6.1. Spain Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.6.2. Key Country Dynamics
8.3.6.3. Regulatory Framework
8.3.6.4. Competitive Scenario
8.3.7. Denmark
8.3.7.1. Denmark Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.7.2. Key Country Dynamics
8.3.7.3. Regulatory Framework
8.3.7.4. Competitive Scenario
8.3.8. Sweden
8.3.8.1. Sweden Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.8.2. Key Country Dynamics
8.3.8.3. Regulatory Framework
8.3.8.4. Competitive Scenario
8.3.9. Norway
8.3.9.1. Norway Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.9.2. Key Country Dynamics
8.3.9.3. Regulatory Framework
8.3.9.4. Competitive Scenario
8.4. Asia Pacific
8.4.1. Asia Pacific Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.2. Japan
8.4.2.1. Japan Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.2.2. Key Country Dynamics
8.4.2.3. Regulatory Framework
8.4.2.4. Competitive Scenario
8.4.3. China
8.4.3.1. China Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.3.2. Key Country Dynamics
8.4.3.3. Regulatory Framework
8.4.3.4. Competitive Scenario
8.4.4. India
8.4.4.1. India Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.4.2. Key Country Dynamics
8.4.4.3. Regulatory Framework
8.4.4.4. Competitive Scenario
8.4.5. South Korea
8.4.5.1. South Korea Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.5.2. Key Country Dynamics
8.4.5.3. Regulatory Framework
8.4.5.4. Competitive Scenario
8.4.6. Australia
8.4.6.1. Australia Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.6.2. Key Country Dynamics
8.4.6.3. Regulatory Framework
8.4.6.4. Competitive Scenario
8.4.7. Thailand
8.4.7.1. Thailand Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.7.2. Key Country Dynamics
8.4.7.3. Regulatory Framework
8.4.7.4. Competitive Scenario
8.5. Latin America
8.5.1. Latin America Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.2. Key Country Dynamics
8.5.3. Regulatory Framework
8.5.4. Competitive Scenario
8.5.5. Brazil
8.5.5.1. Brazil Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.5.2. Key Country Dynamics
8.5.5.3. Regulatory Framework
8.5.5.4. Competitive Scenario
8.5.6. Argentina
8.5.6.1. Argentina Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.6.2. Key Country Dynamics
8.5.6.3. Regulatory Framework
8.5.6.4. Competitive Scenario
8.6. MEA
8.6.1. MEA Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.2.2. Key Country Dynamics
8.6.2.3. Regulatory Framework
8.6.2.4. Competitive Scenario
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.3.2. Key Country Dynamics
8.6.3.3. Regulatory Framework
8.6.3.4. Competitive Scenario
8.6.4. UAE
8.6.4.1. UAE Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.4.2. Key Country Dynamics
8.6.4.3. Regulatory Framework
8.6.4.4. Competitive Scenario
8.6.5. Kuwait
8.6.5.1. Kuwait Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.5.2. Key Country Dynamics
8.6.5.3. Regulatory Framework
8.6.5.4. Competitive Scenario
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.2.1. Acquisition
9.2.2. Collaborations
9.2.3. New Platform Launches
9.2.4. Others
9.3. Company Profiles/Listing
9.3.1. BD (Becton, Dickinson and Company)
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. DiaSorin S.P.A
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Abbott
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Danaher Corporation
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Thermo Fisher Scientific Inc.
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. bioMérieux SA
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. F. Hoffmann-La Roche Ltd.
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives

ページTOPに戻る

List of Tables/Graphs

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 4 Global Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 5 Global Rapid Tests Market, by Application, 2021 - 2033 (USD Million)
Table 6 Global Rapid Tests Market, by End Use, 2021 - 2033 (USD Million)
Table 7 Global Rapid Tests Market, by Region, 2021 - 2033 (USD Million)
Table 8 North America Rapid Tests Market, by Country, 2021 - 2033 (USD Million)
Table 9 North America Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 10 North America Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 11 North America Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 12 North America Rapid Tests Market, by End Use, 2021 - 2033 (USD Million)
Table 13 U.S. Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 14 U.S. Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 15 U.S. Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 16 U.S. Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 17 Canada Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 18 Canada Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 19 Canada Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 20 Canada Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 21 Mexico Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 22 Mexico Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 23 Mexico Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 24 Mexico Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 25 Europe Rapid Tests Market, by Country, 2021 - 2033 (USD Million)
Table 26 Europe Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 27 Europe Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 28 Europe Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 29 Europe Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 30 UK Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 31 UK Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 32 UK Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 33 UK Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 34 Germany Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 35 Germany Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 36 Germany Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 37 Germany Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 38 France Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 39 France Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 40 France Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 41 France Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 42 Italy Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 43 Italy Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 44 Italy Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 45 Italy Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 46 Spain Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 47 Spain Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 48 Spain Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 49 Spain Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 50 Norway Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 51 Norway Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 52 Norway Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 53 Norway Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 54 Sweden Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 55 Sweden Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 56 Sweden Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 57 Sweden Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 58 Denmark Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 59 Denmark Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 60 Denmark Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 61 Denmark Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 62 Asia Pacific Rapid Tests Market, by Country, 2021 - 2033 (USD Million)
Table 63 Asia Pacific Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 64 Asia Pacific Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 65 Asia Pacific Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 66 Asia Pacific Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 67 Japan Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 68 Japan Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 69 Japan Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 70 Japan Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 71 China Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 72 China Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 73 China Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 74 China Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 75 India Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 76 India Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 77 India Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 78 India Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 79 Australia Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 80 Australia Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 81 Australia Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 82 Australia Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 83 South Korea Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 84 South Korea Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 85 South Korea Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 86 South Korea Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 87 Thailand Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 88 Thailand Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 89 Thailand Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 90 Thailand Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 91 Latin America Rapid Tests Market, by Country, 2021 - 2033 (USD Million)
Table 92 Latin America Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 93 Latin America Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 94 Latin America Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 95 Latin America Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 96 Brazil Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 97 Brazil Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 98 Brazil Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 99 Brazil Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 100 Argentina Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 101 Argentina Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 102 Argentina Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 103 Argentina Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 104 Middle East Africa Rapid Tests Market, by Country, 2021 - 2033 (USD Million)
Table 105 Middle East Africa Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 106 Middle East Africa Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 107 Middle East Africa Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 108 Middle East Africa Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 109 South Africa Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 110 South Africa Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 111 South Africa Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 112 South Africa Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 113 Saudi Arabia Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 114 Saudi Arabia Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 115 Saudi Arabia Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 116 Saudi Arabia Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 117 UAE Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 118 UAE Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 119 UAE Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 120 UAE Rapid Tests Market by End Use, 2021 - 2033 (USD Million)
Table 121 Kuwait Rapid Tests Market, by Product, 2021 - 2033 (USD Million)
Table 122 Kuwait Rapid Tests Market, by Technology, 2021 - 2033 (USD Million)
Table 123 Kuwait Rapid Tests Market by Application, 2021 - 2033 (USD Million)
Table 124 Kuwait Rapid Tests Market by End Use, 2021 - 2033 (USD Million)List of Figures

Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Market Segmentation
Fig. 8 Market Snapshot, 2025
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Market Penetration & Growth Prospect Mapping, 2025
Fig. 15 Global Rapid Tests Market: Product Movement Analysis
Fig. 16 Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 17 Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 18 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 19 Rapid testing technology outlook: Key takeaways
Fig. 20 Rapid Tests Market: Technology movement analysis (USD Million)
Fig. 21 Molecular Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 22 Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 23 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 24 Rapid testing application outlook: Key takeaways
Fig. 25 Rapid testing market: Application movement analysis (USD Million)
Fig. 26 Respiratory tract infections, 2021 - 2033 (USD Million)
Fig. 27 Influenza and Parainfluenza Virus, 2021 - 2033 (USD Million)
Fig. 28 Respiratory Syncytial Virus, 2021 - 2033 (USD Million)
Fig. 29 Streptococcus, 2021 - 2033 (USD Million)
Fig. 30 Other, 2021 - 2033 (USD Million)
Fig. 31 Sexually Transmitted Infections (STIs), 2021 - 2033 (USD Million)
Fig. 32 Antibiotic-Resistant Infections (MRSA, Streptococcus Pneumonia, and Others), 2021 - 2033 (USD Million)
Fig. 33 Gastrointestinal Infections, 2021 - 2033 (USD Million)
Fig. 34 Sepsis, 2021 - 2033 (USD Million)
Fig. 35 Bacterial Sepsis, 2021 - 2033 (USD Million)
Fig. 36 Fungal Sepsis and Others, 2021 - 2033 (USD Million)
Fig. 37 Tropical & Vector-borne Diseases, 2021 - 2033 (USD Million)
Fig. 38 Other, 2021 - 2033 (USD Million)
Fig. 39 Rapid testing end-use outlook: Key takeaways
Fig. 40 Rapid Tests Market: End Use movement analysis (USD Million)
Fig. 41 Hospitals & clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 42 Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 43 At-home testing and others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 44 Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 45 Regional Marketplace: Key Takeaways
Fig. 46 Regional Outlook, 2025 & 2033
Fig. 47 Global Rapid Tests Market: Regional Movement Analysis
Fig. 48 North America Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 49 U.S. Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 50 Canada Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 51 Mexico Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 52 Europe Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 53 Germany Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 54 UK Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 55 France Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 56 Italy Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 57 Spain Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 58 Denmark Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 59 Sweden Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 60 Norway Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 61 Asia Pacific Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 62 Japan Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 63 China Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 64 India Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 65 Australia Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 66 South Korea Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 67 Thailand Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 68 Latin America Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 69 Brazil Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 70 Argentina Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 71 Middle East and Africa Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 72 South Africa Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 73 Saudi Arabia Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 74 UAE Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 75 Kuwait Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)